SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments
Members of the SEISMIC project team Members of the SEISMIC project team SEISMIC Kickoff Meeting at Philips in Best, the...
Members of the SEISMIC project team Members of the SEISMIC project team SEISMIC Kickoff Meeting at Philips in Best, the...
Surge in the prevalence of chronic diseases such as cancer & cardiovascular diseases and advancements in technology drive the growth...
Two-Day Forum Offers an Opportunity to Network with Industry Leaders Exploring Neurotech Investment OpportunitiesInnovative companies advancing neurotechnology, including BCI, neuromodulation,...
Acquisition strengthens the group's portfolio with expertise in high-science and evidence-driven strategy and creative DALLAS, Feb. 10, 2026 /PRNewswire/ --...
BELFAST, Northern Ireland, Feb. 10, 2026 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on...
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is...
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the...
Patient catchment now includes 187 million+ patient lives, enables advanced analytics and AI modeling for diverse, under-represented patient populationsZURICH, Feb....
New digital health communities for Cancer, Idiopathic Hypersomnia, and Primary Biliary Cholangitis (PBC) underscore Health Union's gold-standard approach to patient...
Doubling of VEVYE® Sales Force is On Track, Expansion of IHEEZO® Commercial Footprint to the Office-Based Setting Underway, and Doubling TRIESENCE®...
Mount Sinai and BPGbio scientists uncover novel molecular drivers from live brain samples that direct human brain structure and function...
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders Tevogen Board to Evaluate Potential One-Time Special Cash Dividend...
• Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’...
Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in...
Ad hoc announcement pursuant to Art. 53 LR Regulatory dossier to obtain marketing authorization for QUVIVIQ has been submitted to...
Arbor Scientia Group has been assisting clients with a new online educational excellence course model designed to improve engagement, retention, and...
NEWARK, Del., Jan. 22, 2026 /PRNewswire/ -- The global optical coherence tomography (OCT) market is forecast to expand at a...
Recognition based on innovation, growth, strategic initiatives and robust partnerships indelivering regulatory-grade RWESAN FRANCISCO, Jan. 22, 2026 /PRNewswire/ -- Verana Health®,...
Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics.CAMBRIDGE, Mass., Jan....
Dr. Miller’s appointment further enhances NKGen’s scientific and clinical advisory capabilities as the Company advances its research in Alzheimer’s and...